India will lower prices for 137 cancer drugs from next month after Sarojam Radhakrishnan, unable to afford breast cancer treatment costing over 63,000 rupees a month, took her case to court. Supreme court judges called mark-ups “extortion”, citing a drug sold to hospitals for 2,700 rupees and priced